123 related articles for article (PubMed ID: 12679194)
1. Enhancer substances: selegiline and R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane [(-)-BPAP] enhance the neurotrophic factor synthesis on cultured mouse astrocytes.
Shimazu S; Tanigawa A; Sato N; Yoneda F; Hayashi K; Knoll J
Life Sci; 2003 May; 72(24):2785-92. PubMed ID: 12679194
[TBL] [Abstract][Full Text] [Related]
2. The novel catecholaminergic and serotoninergic activity enhancer R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane up-regulates neurotrophic factor synthesis in mouse astrocytes.
Ohta K; Ohta M; Mizuta I; Fujinami A; Shimazu S; Sato N; Yoneda F; Hayashi K; Kuno S
Neurosci Lett; 2002 Aug; 328(3):205-8. PubMed ID: 12147307
[TBL] [Abstract][Full Text] [Related]
3. Selegiline and desmethylselegiline stimulate NGF, BDNF, and GDNF synthesis in cultured mouse astrocytes.
Mizuta I; Ohta M; Ohta K; Nishimura M; Mizuta E; Hayashi K; Kuno S
Biochem Biophys Res Commun; 2000 Dec; 279(3):751-5. PubMed ID: 11162424
[TBL] [Abstract][Full Text] [Related]
4. (-)1-(Benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain.
Knoll J; Yoneda F; Knoll B; Ohde H; Miklya I
Br J Pharmacol; 1999 Dec; 128(8):1723-32. PubMed ID: 10588928
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of the catecholaminergic and serotoninergic neurons in the rat brain by R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane, (-)-BPAP.
Knoll J; Miklya I; Knoll B
Life Sci; 2002 Sep; 71(18):2137-44. PubMed ID: 12204771
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity studies leading to (-)1-(benzofuran-2-yl)-2-propylaminopentane, ((-)BPAP), a highly potent, selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain.
Yoneda F; Moto T; Sakae M; Ohde H; Knoll B; Miklya I; Knoll J
Bioorg Med Chem; 2001 May; 9(5):1197-212. PubMed ID: 11377178
[TBL] [Abstract][Full Text] [Related]
7. Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage.
Semkova I; Wolz P; Schilling M; Krieglstein J
Eur J Pharmacol; 1996 Nov; 315(1):19-30. PubMed ID: 8960860
[TBL] [Abstract][Full Text] [Related]
8. Riluzole stimulates nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis in cultured mouse astrocytes.
Mizuta I; Ohta M; Ohta K; Nishimura M; Mizuta E; Kuno S
Neurosci Lett; 2001 Sep; 310(2-3):117-20. PubMed ID: 11585581
[TBL] [Abstract][Full Text] [Related]
9. Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes.
Ohta K; Kuno S; Mizuta I; Fujinami A; Matsui H; Ohta M
Life Sci; 2003 Jun; 73(5):617-26. PubMed ID: 12770616
[TBL] [Abstract][Full Text] [Related]
10. A longevity study with enhancer substances (selegiline, BPAP) detected an unknown tumor-manifestation-suppressing regulation in rat brain.
Knoll J; Baghy K; Eckhardt S; Ferdinandy P; Garami M; Harsing LG; Hauser P; Mervai Z; Pocza T; Schaff Z; Schuler D; Miklya I
Life Sci; 2017 Aug; 182():57-64. PubMed ID: 28623006
[TBL] [Abstract][Full Text] [Related]
11. 1-(Benzofuran-2-yl)-2-(3,3,3-trifluoropropyl)aminopentane HCl, 3-F-BPAP, antagonizes the enhancer effect of (-)-BPAP in the shuttle box and leaves the effect of (-)-deprenyl unchanged.
Knoll J; Miklya I; Knoll B; Yasusa T; Shimazu S; Yoneda F
Life Sci; 2002 Sep; 71(17):1975-84. PubMed ID: 12175892
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective function of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane, [R-(-)-BPAP], against apoptosis induced by N-methyl(R)salsolinol, an endogenous dopaminergic neurotoxin, in human dopaminergic neuroblastoma SH-SY5Y cells.
Maruyama W; Yi H; Takahashi T; Shimazu S; Ohde H; Yoneda F; Iwasa K; Naoi M
Life Sci; 2004 May; 75(1):107-17. PubMed ID: 15102525
[TBL] [Abstract][Full Text] [Related]
13. The use of the synthetic enhancer substances (-)-deprenyl and (-)-BPAP in major depression.
Gaszner P; Miklya I
Neuropsychopharmacol Hung; 2004 Dec; 6(4):210-20. PubMed ID: 15825677
[TBL] [Abstract][Full Text] [Related]
14. Apomorphine up-regulates NGF and GDNF synthesis in cultured mouse astrocytes.
Ohta M; Mizuta I; Ohta K; Nishimura M; Mizuta E; Hayashi K; Kuno S
Biochem Biophys Res Commun; 2000 May; 272(1):18-22. PubMed ID: 10872797
[TBL] [Abstract][Full Text] [Related]
15. Transporter-mediated actions of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane.
Shimazu S; Tsunekawa H; Yoneda F; Katsuki H; Akaike A; Janowsky A
Eur J Pharmacol; 2003 Dec; 482(1-3):9-16. PubMed ID: 14659999
[TBL] [Abstract][Full Text] [Related]
16. Cabergoline stimulates synthesis and secretion of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor by mouse astrocytes in primary culture.
Ohta K; Fujinami A; Kuno S; Sakakimoto A; Matsui H; Kawahara Y; Ohta M
Pharmacology; 2004 Jul; 71(3):162-8. PubMed ID: 15161999
[TBL] [Abstract][Full Text] [Related]
17. (-)-1-(Benzofuran-2-yl)-2-propylaminopentane enhances locomotor activity in rats due to its ability to induce dopamine release.
Shimazu S; Takahata K; Katsuki H; Tsunekawa H; Tanigawa A; Yoneda F; Knoll J; Akaike A
Eur J Pharmacol; 2001 Jun; 421(3):181-9. PubMed ID: 11516435
[TBL] [Abstract][Full Text] [Related]
18. Cytoprotective effect of two synthetic enhancer substances, (-)-BPAP and (-)-deprenyl, on human brain capillary endothelial cells and rat PC12 cells.
Denes L; Szilágyi G; Gál A; Bori Z; Nagy Z
Life Sci; 2006 Aug; 79(11):1034-9. PubMed ID: 16624331
[TBL] [Abstract][Full Text] [Related]
19. Major depression and the synthetic enhancer substances, (-)-deprenyl and R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane.
Gaszner P; Miklya I
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):5-14. PubMed ID: 16023777
[TBL] [Abstract][Full Text] [Related]
20. Effects of R-(-)-BPAP on the expressions of neurotrophins and their receptors in mesencephalic slices.
Hirami C; Takahata K; Shimazu S; Yoneda F; Hayashi K; Katsuki H; Akaike A
Biol Pharm Bull; 2005 Aug; 28(8):1524-6. PubMed ID: 16079507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
